Angiogenin and SDF-1α serum concentration in patients with systemic sclerosis in relation to clinical status

Archives of Medical Science

Volumn 7, Issue 1, 2011, Pages 92-96

  Dziankowska Bartkowiak, Bozena ^a   Gerlicz Kowalczuk, Zofia ^a   Waszczykowska, Elzbieta ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Angiogenesis; Angiogenin; SDF 1 ; Systemic sclerosis; Vasculogenesis

Indexed keywords

ANGIOGENIN; CHEMOKINE; STROMAL CELL DERIVED FACTOR 1ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; DISEASE DURATION; ENDOTHELIUM LESION; FEMALE; HUMAN; HYPOXIA; MALE; RAYNAUD PHENOMENON; REVASCULARIZATION; SCLERODERMA; SCORING SYSTEM; SYSTEMIC SCLEROSIS;

EID: 79952523508     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2011.20610     Document Type: Article

References (25)

1. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, Thistletwaite PA. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 2000; 342: 626-33. (Pubitemid 30118415)
2. Kuwana M, Okazaki Y, Yasuoka H, Kawakami Y, Ikeda Y. Defective vasculogenesis in systemi sclerosis. Lancet 2004; 364: 603-10.
3. Jo DY, Rafii S, Hamada T, Moore MA. Chemotaxis of primitive hematopoietic cells in response to stroma cell-derived factor-1. J Clin Invest 2000; 105: 101-11. (Pubitemid 30036392)
4. Aghi M, Cohen KS, Klein RJ, Scadden DT, Chiocca EA. Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes. Cancer Res 2006; 66: 9054-64. (Pubitemid 44521124)
5. Pablos JL, Amara A, Bouloc A, et al. Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin. Am J Pathol 1999; 155: 1577-86.
6. Cipriani P, Franca Milia A, Liakouli V, et al. Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implication. Arthritis Rheum 2006; 54: 3022-33. (Pubitemid 44497784)
7. Hu G, Riordan JF, Vallee L. Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities. Proc Natl Acad Sci USA 1994; 91: 12096-100. (Pubitemid 24368611)
8. Hu GF, Strydom DJ, Fett JW, Riordan JF, Vallee BL. Actin is a binding protein for angiogenin. Proc Natl Acad Sci USA 1993; 90: 1217-21. (Pubitemid 23058142)
9. Soncin F. Angiogenin supports endothelial and fibroblast cell adhesion. Proc Natl Acad Sci USA 1992; 89: 2232-6.
10. Subcomittee for Scleroderma Criteria of American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
11. Medsger TA Jr, Bomardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W. Assesment of disease severity and prognosis. Clin Exp Rheumatolo 2003; 21 (3 Suppl. 29): S42-6.
12. Kahaleh MB, Suttany GL, Smith EA, Huffstutter JE, Loadholt CB, LeRoy EC. A modified scleroderma skin score method. Clin Exp Rheumatol 1986; 4: 367-9. (Pubitemid 17223177)
13. Alivernini S, De Santis M, Tolusso B, et al. Skin ulcers in systemic sclerosis: determinants of presence and predictive factors of healing. J Am Acad Dermatol 2009; 60: 426-35.
14. Avouac J, Wipff J, Goldman O, et al. Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions. Arthritis Rheum 2008; 58: 3550-61.
15. Cipriani P, Guiducci S, Miniati I, et al. Impairment of endothelial cell differentation from bone marrow - derived mesenchymal stem cells. Arthritis Rheum 2007; 56: 1994-2004.
16. Shimoyama S, Kaminishi M. Angiogenin in sera as an independent prognostic factor in gastric cancer. J Cancer Res Clin Oncol 2003; 129: 239-44. (Pubitemid 36713800)
17. Patel JV, Sosin M, Gunarathne A, et al. Elevated angiogenin levels in chronic heart failure. Ann Med 2008; 40: 474-9.
18. Tello-Montoliu A, Marín F, Patel J, et al. Plasma angiogenin levels in acute coronary syndromes: implications of prognosis. Eur Heart 2007; 28: 3006-11. (Pubitemid 350262264)
19. McHugh NJ, Distler O, Giacomelli R, Riemekasten G. Non organ based laboratory markers in systemic sclerosis. Clin Exp Rheumatol 2003; 21 (3 Suppl 29): S32-8.
20. Scheja A, Akesson A, Geborek P, et al. Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma). Arthritis Res 2001; 3: 178-82. (Pubitemid 32303434)
21. Kortesidis A, Zannettino A, Isenmann S, Shi S, Lapidot T, Gronthos S. Stromal-derived factor-1 promotes the growth, survival and development of human bone marrow stromal stem cells. Blood 2005; 105: 2643-5.
22. Cipriani P, Franca Milia A, Liakouli V, et al Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications. Arthritis Rheum 2006; 54: 3022-33. (Pubitemid 44497784)
23. Campioni D, Lo Monaco A, Lanza F, et al. CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis. Haematologica 2008; 93: 1233-7.
24. Askari AT, Unzek S, Popovic ZB, et al. Effect of stromal-cell-derived factor 1 on stem cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003; 362: 697-703. (Pubitemid 37101067)
25. Manetti M, Liakouli V, Fatini C, et al. Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis. Ann Rheum Dis 2009; 68: 408-11.